EUDA (EUDA Health Holdings Limited Ordinary Shares) Stock Analysis - Analyst Ratings

EUDA Health Holdings Limited Ordinary Shares (EUDA) is a publicly traded Healthcare sector company. As of May 21, 2026, EUDA trades at $18.00 with a market cap of $36.47M and a P/E ratio of -8.79. EUDA moved +6.57% today. Year to date, EUDA is -60.70%; over the trailing twelve months it is -76.83%. Its 52-week range spans $5.26 to $126.00. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces EUDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate EUDA?

1 analysts cover EUDA: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $2.75.

EUDA Key Metrics

Key financial metrics for EUDA
MetricValue
Price$18.00
Market Cap$36.47M
P/E Ratio-8.79
EPS$-2.07
Dividend Yield0.00%
52-Week High$126.00
52-Week Low$5.26
Volume956
Avg Volume0
Revenue (TTM)$9.84M
Net Income$-24.95M
Gross Margin34.09%

EUDA Analyst Consensus

1 analysts cover EUDA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.75.

Latest EUDA News

Common questions about EUDA

What do analysts rate EUDA?
1 analysts cover EUDA: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $2.75.
Does Rallies show EUDA price targets?
Yes. Rallies tracks EUDA analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is EUDA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EUDA. It does not provide personalized investment advice.
EUDA

EUDA